Viracta Therapeutics Stock Technical Analysis
VIRXDelisted Stock | USD 0.03 0 7.38% |
As of the 26th of March, Viracta Therapeutics has the Variance of 141.9, risk adjusted performance of (0.13), and Coefficient Of Variation of (605.13). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Viracta Therapeutics, as well as the relationship between them.
Viracta Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Viracta, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ViractaViracta |
Viracta Therapeutics technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Viracta Therapeutics Technical Analysis
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.
Viracta Therapeutics Trend Analysis
Use this graph to draw trend lines for Viracta Therapeutics. You can use it to identify possible trend reversals for Viracta Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Viracta Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Viracta Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Viracta Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.0006 , which may suggest that Viracta Therapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 0.01, which is the sum of squared deviations for the predicted Viracta Therapeutics price change compared to its average price change.About Viracta Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Viracta Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Viracta Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Viracta Therapeutics price pattern first instead of the macroeconomic environment surrounding Viracta Therapeutics. By analyzing Viracta Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Viracta Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Viracta Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
Viracta Therapeutics March 26, 2025 Technical Indicators
Most technical analysis of Viracta help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Viracta from various momentum indicators to cycle indicators. When you analyze Viracta charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Risk Adjusted Performance | (0.13) | |||
Market Risk Adjusted Performance | 0.9885 | |||
Mean Deviation | 7.32 | |||
Coefficient Of Variation | (605.13) | |||
Standard Deviation | 11.91 | |||
Variance | 141.9 | |||
Information Ratio | (0.17) | |||
Jensen Alpha | (1.97) | |||
Total Risk Alpha | (2.02) | |||
Treynor Ratio | 0.9785 | |||
Maximum Drawdown | 76.98 | |||
Value At Risk | (14.49) | |||
Potential Upside | 12.5 | |||
Skewness | (2.32) | |||
Kurtosis | 8.56 |
Viracta Therapeutics March 26, 2025 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Viracta stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution | 0.28 | ||
Daily Balance Of Power | (0.20) | ||
Rate Of Daily Change | 0.93 | ||
Day Median Price | 0.04 | ||
Day Typical Price | 0.03 | ||
Price Action Indicator | (0.01) | ||
Market Facilitation Index | 0.01 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in Viracta Pink Sheet
If you are still planning to invest in Viracta Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Viracta Therapeutics' history and understand the potential risks before investing.
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |